When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NBRV - Nabriva's lefamulin shows positive effect in lung inflammation model
Nabriva Therapeutics plc
Nabriva Therapeutics (NASDAQ:NBRV)announces encouraging results from a preclinical study assessing oral antibiotic Xenleta (lefamulin) in a mouse model of lipopolysaccharide (LPS)-induced lung neutrophilia (induced lung inflammation via intranasal administration of LPS).
More news on: Nabriva Therapeutics plc, Healthcare stocks news, Stocks on the move,